UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reply to: Temporary Like Achilles: Pre‐emptive germline pharmacogenetic testing

Basic & clinical pharmacology & toxicology, 2023-10, Vol.133 (4), p.400-401

2023

Volltextzugriff (PDF)

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Clinical and translational science, 2020-01, Vol.13 (1), p.116-124

2020

Volltextzugriff (PDF)

Liposomal drug formulations in cancer therapy: 15 years along the road

Drug discovery today, 2012-02, Vol.17 (3-4), p.160-166

2012

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

Clinical pharmacology and therapeutics, 2018-05, Vol.103 (5), p.770-777

2018

Volltextzugriff (PDF)

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines

European journal of human genetics : EJHG, 2020-04, Vol.28 (4), p.508-517

2020

Volltextzugriff (PDF)

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Clinical pharmacology and therapeutics, 2019-10, Vol.106 (4), p.866-873

2019

Volltextzugriff (PDF)

Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

Clinical pharmacology and therapeutics, 2021-03, Vol.109 (3), p.591-604

2021

Volltextzugriff (PDF)

Liver and kidney function in patients with Covid‐19 treated with remdesivir

British journal of clinical pharmacology, 2021-11, Vol.87 (11), p.4450-4454

2021

Volltextzugriff (PDF)

Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

European journal of cancer (1990), 2020-12, Vol.141, p.9-20

2020

Volltextzugriff (PDF)

Pharmacogenomics, a novel section in the European Journal of Human Genetics

European journal of human genetics : EJHG, 2018-10, Vol.26 (10), p.1399-1400

Guchelaar, Henk-Jan

2018

Volltextzugriff (PDF)

Clinical pharmacokinetics of tyrosine kinase inhibitors

Cancer treatment reviews, 2009-12, Vol.35 (8), p.692-706

2009

Volltextzugriff (PDF)

Estimating the potential impact of implementing pre‐emptive pharmacogenetic testing in primary care across the UK

British journal of clinical pharmacology, 2021-07, Vol.87 (7), p.2907-2925

2021

Volltextzugriff (PDF)

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors

CPT: pharmacometrics and systems pharmacology, 2019-10, Vol.8 (10), p.720-737

2019

Volltextzugriff (PDF)

Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device

British journal of clinical pharmacology, 2018-12, Vol.84 (12), p.2889-2902

2018

Volltextzugriff (PDF)

Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

British journal of clinical pharmacology, 2023-12

2023

Volltextzugriff (PDF)

The PREPARE study: benefits of pharmacogenetic testing are unclear – Authors' reply

The Lancet (British edition), 2023-06, Vol.401 (10391), p.1851-1852

2023

Volltextzugriff (PDF)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

European journal of clinical pharmacology, 2017-10, Vol.73 (10), p.1247-1252

2017

Volltextzugriff (PDF)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2890

2020

Volltextzugriff (PDF)

A Genome‐Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early‐Stage Breast Cancer Patients

Clinical pharmacology and therapeutics, 2024-07, Vol.116 (1), p.155-164

2024

Volltextzugriff (PDF)

Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy

Clinical pharmacology and therapeutics, 2024-06, Vol.115 (6), p.1282-1292

2024

Volltextzugriff (PDF)

Self‐management support with the Respiratory Adherence Care Enhancer instrument in asthma and chronic obstructive pulmonary disease: An implementation trial

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1344-1356

2024

Volltextzugriff (PDF)

An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell Carcinoma

Clinical pharmacology and therapeutics, 2020-09, Vol.108 (3), p.644-652

2020

Volltextzugriff (PDF)

Validation of transcriptome signature reversion for drug repurposing in oncology

Briefings in bioinformatics, 2023-01, Vol.24 (1)

2023

Volltextzugriff (PDF)

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study

Journal of clinical oncology, 2019-03, Vol.37 (8), p.636-646

2019

Volltextzugriff (PDF)

Detecting DPD deficiency: when perfect is the enemy of good

Cancer chemotherapy and pharmacology, 2021-05, Vol.87 (5), p.717-719

2021

Volltextzugriff (PDF)

1 – 25 von 444

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(351)

Publikationsform

Artikel
(442)
Berichte
(1)
Reviews
(1)

Sprache

Englisch
(443)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Reply to: Temporary Like Achilles: Pre‐emptive germline pharmacogenetic testing

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Liposomal drug formulations in cancer therapy: 15 years along the road

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

Liver and kidney function in patients with Covid‐19 treated with remdesivir

Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

Pharmacogenomics, a novel section in the European Journal of Human Genetics

Clinical pharmacokinetics of tyrosine kinase inhibitors

Estimating the potential impact of implementing pre‐emptive pharmacogenetic testing in primary care across the UK

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors

Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device

Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

The PREPARE study: benefits of pharmacogenetic testing are unclear – Authors' reply

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

A Genome‐Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early‐Stage Breast Cancer Patients

Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy

Self‐management support with the Respiratory Adherence Care Enhancer instrument in asthma and chronic obstructive pulmonary disease: An implementation trial

An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell Carcinoma

Validation of transcriptome signature reversion for drug repurposing in oncology

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study

Detecting DPD deficiency: when perfect is the enemy of good

Suchergebnisse filtern